In this study, we showed a clear decrease in the CD10 receptor on neutrophils in all COVID-19 severity groups that are admitted to the hospital, indicating that decreased CD10 on neutrophils might be involved in the compromised bradykinin pathway in COVID-19 patients. This evidence concerns the gene KNG1 and COVID-19.